1.Abdellatief, S.A., Galal, A.A., Farouk, S.M. and Abdel- Daim, M.M. 2017. Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed. Pharmacother., 86: 482-491.

2.Amalraj, A. and Gopi, S. 2017. Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: a review. J. Tradit. Complement. Med., 7(1): 65-78.

3.Bentli, R., Parlakpinar, H., Polat, A., Samdanci, E., Sarihan, M.E. and Sagir, M. 2013. Molsidomine prevents cisplatininduced hepatotoxicity. Arch. Med. Res., 44(7): 521-528.

4.Cure, M.C., Cure, E., Kalkan, Y., Kirba?, A., Tumkaya, L., Yilmaz, A. and Yuce, S. 2016. Infliximab modulates cisplatininduced hepatotoxicity in rats. Balkan Med. J., 33(5): 504.

5.Dasari, S. and Tchounwou, P.B. 2014. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol., 740: 364-378.

6.De Luca, A., Parker, L.J., Ang, W.H., Rodolfo, C., Gabbarini, V., Hancock, N.C. and Dyson, P.J. 2019. A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1. Proc. Natl. Acad. Sci., 116(28): 13943- 13951.

7.Florea, A.M. and Busselberg, D. 2011. Cisplatin as an antitumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancer., 3(1): 1351-1371.

8.Ginguay, A., De Bandt, J.P. and Cynober, L. 2016. Indications and contraindications for infusing specific amino acids (leucine, glutamine, arginine, citrulline, and taurine) in critical illness. Curr. Opin. Clin. Nutr. Metab. Care., 19 (2): 161-169.

9.Horinouchi, H., Kubota, K., Itani, H., Taniyama, T.K., Nakamichi, S., Wakui, H. and Tamura, T. 2013. Short hydration in chemotherapy containing cisplatin (≥ 75 mg/ m2) for patients with lung cancer: a prospective study. Jpn. J. Clin. Oncol., 43(11): 1105-1109.

10.Jadon, A.S., Bhadauriya, P. and Sharma, M. 2019. An integrative review of Cisplatin: the first metal Anti-Tumor drug. J. Drug Deliv. Ther., 9(3): 673-677.

11.Jamdade, V.S., Mundhe, N.A., Kumar, P., Tadla, V. and Lahkar, M. 2016. Raloxifene inhibits NF-kB pathway and potentiates anti-tumour activity of cisplatin with simultaneous reduction in its nephrotoxictiy. Pathol. Oncol. Res., 22(1): 145-153.

12.Karale, S. and Kamath, J. V. 2017. Effect of daidzein on cisplatininduced hematotoxicity and hepatotoxicity in experimental rats. Indian J. Pharmacol., 49(1): 49.

13.Karimi, S., Hosseinimehr, S.J., Mohammadi, H.R., Khalatbary, A.R. and Amiri, F.T. 2018. Zatariamultiflora ameliorates cisplatin-induced testicular damage via suppression of oxidative stress and apoptosis in a mice model. Iran. J. Basic Med. Sci., 21(6): 607.

14.Khan, M.S.A. and Ahmad, I. 2019. Herbal medicine: Current trends and future aspects. New look into Phytomedicine, Advancements in herbal products as novel drug leads, pp. 3-13. India: Academic Press.

15.Khan, R., Khan, A.Q., Qamar, W., Lateef, A., Ali, F., Rehman, M.U. and Sultana, S. 2012. Chrysin abrogates cisplatininduced oxidative stress, p53 expression, goblet cell disintegration and apoptotic responses in the jejunum of Wistar rats. Br. J. Nutr., 108(9): 1574-1585.

16.Manohar, S. and Leung, N. 2018. Cisplatin nephrotoxicity: a review of the literature. J. Nephrol., 31 (1): 15-25.

17.Okon, E., Luszczki, J.J., Kukula-Koch, W., Halasa, M., Jarzab, A., Khurelbat, D. and Wawruszak, A. 2020. Synergistic or additive pharmacological interactions between magnoflorine and cisplatin in human cancer cells of different histological origin. Int. J. Mol. Sci., 21(8): 2848.

18.Paarakh, P. M. 2010. Terminalia arjuna (Roxb.) Wt. and Arn.: a review. Int. J. Pharmacol., 6(5): 515-534.

19.Pinar, N., Cakirca, G., Hakverdi, S. and Kaplan, M. 2020. Protective effect of alpha lipoic acid on cisplatin induced hepatotoxicity in rats. Biotech. Histochem., 95(3): 219-224.

20.Raj, S., Singh, H., Trivedi, R. and Soni, V. 2020. Biogenic synthesis of AgNPs employing Terminalia arjuna leaf extract and its efficacy towards catalytic degradation of organic dyes. Sci. Rep., 10(1): 1-10.

21.Ramya, B., Anjaneyulu, Y., Reddy, A. G., Madhuri, D., Lakshman, M. and Shivakumar, P. 2013. Protective role of turmeric on histological, ultrastructural and sero-biochemical changes in cisplatin-induced nephrotoxicity in female rats. Vet. World, 6(11): 865.

22.Sahu, B.D., Kalvala, A.K., Koneru, M., Kumar, J.M., Kuncha, M., Rachamalla, S.S. and Sistla, R. 2014. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PLoS One., 9(9): e105070.

23.Schaffer, S. and Kim, H. W. 2018. Effects and mechanisms of taurine as a therapeutic agent. Biomol. Ther., 26(3): 225.

24.Sherif, I.O. 2015. Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoidsaponin of Terminalia arjuna. Clin. Exp. Nephrol., 19(4): 591-597.

25.Un, H., Ugan, R.A., Kose, D., Bayir, Y., Cadirci, E., Selli, J. and Halici, Z. 2020. A novel effect of Aprepitant: Protection for cisplatin-induced nephrotoxicity and hepatotoxicity. Eur. J. Pharmacol.,173168.

26.Waseem, M., Pandey, P., Tomar, B., Raisuddin, S. and Parvez, S. 2014. Ameliorative action of curcumin in cisplatin-mediated hepatotoxicity: an in vivo study in Wistar rats. Arch. Med. Res., 45(6): 462-468.

27.Yousef, M. I. andHussien, H.M. 2015. Cisplatin-induced renal toxicity via tumor necrosis factor-α, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem. Toxicol., 78: 17-25.

28.Zhu, H., Luo, H., Zhang, W., Shen, Z., Hu, X. and Zhu, X. 2016. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Des. Devel. Ther., 10: 1885.